Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration
06/01/2025 14:53
Jan 6 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS INC: ANNOUNCES SUCCESSFUL SYNTHESIS
OF
NOVEL SMALL-MOLECULE DRUG CANDIDATES DESIGNED UNDER AI PLATFORM
COLLABORATION
Source text: urn:newsml:reuters.com:*:nGNX9jhvNQ
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration